Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Epithelial Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05055167
What this trial is testing

Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IV
The First Affiliated Hospital of Xiamen University 20
Not applicableLooking for participantsNCT06221800
What this trial is testing

Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects

Who this might be right for
Non Small Cell Lung Cancer
University of California, Irvine 82
Early research (Phase 1)Study completedNCT02009436
What this trial is testing

Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
Albert Einstein College of Medicine 8
Testing effectiveness (Phase 2)Study completedNCT00807300
What this trial is testing

Computed Tomography (CT) - Guided Brachytherapy Versus Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of Magdeburg 77
Testing effectiveness (Phase 2)Ended earlyNCT01111292
What this trial is testing

Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia

Who this might be right for
Colon CarcinomaDysplasia in Crohn DiseaseLow Grade Dysplasia in Ulcerative Colitis+1 more
National Cancer Institute (NCI) 5
Early research (Phase 1)UnknownNCT05883007
What this trial is testing

Dose Optimized BNCT for Head and Neck Cancer

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma
Southern Tohoku BNCT Research Center 30
Testing effectiveness (Phase 2)UnknownNCT05267392
What this trial is testing

Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or Chemoradiotherapy

Who this might be right for
Non-small Cell Lung Cancer
Instituto Portugues de Oncologia, Francisco Gentil, Porto 30
Large-scale testing (Phase 3)WithdrawnNCT03048136
What this trial is testing

A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb
Not applicableStudy completedNCT05375136
What this trial is testing

Lenvatinib in Combination With Pembrolizumab in Korean Patients

Who this might be right for
Endometrial NeoplasmsEndometriumCarcinoma+1 more
Eisai Korea Inc. 135
Not applicableUnknownNCT04852211
What this trial is testing

Laparoscopic Versus Open Major Hepatectomy for HCC Hepatectomy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Chinese University of Hong Kong 212
Early research (Phase 1)Study completedNCT02271711
What this trial is testing

Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors

Who this might be right for
Recurrent Childhood MedulloblastomaRecurrent EpendymomaRecurrent Medulloblastoma
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT01160744
What this trial is testing

Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 280
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07644208
What this trial is testing

PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative Hepatectomy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shanghai Zhongshan Hospital 30
Not applicableNo Longer AvailableNCT01947608
What this trial is testing

Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT01346540
What this trial is testing

A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology.

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 16
Early research (Phase 1)Active Not RecruitingNCT02474368
What this trial is testing

Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck

Who this might be right for
Recurrent Head and Neck CarcinomaHead and Neck Cancer MetastaticHead or Neck Cancer
Dana-Farber Cancer Institute 21
Testing effectiveness (Phase 2)Study completedNCT01265368
What this trial is testing

A Clinical Study to Assess Safety and Efficacy of a Tumor Vaccine in Patients With Advanced Renal Cell Carcinoma (ASET)

Who this might be right for
Stage IV Renal Cell Cancer
Mologen AG 19
Testing effectiveness (Phase 2)Looking for participantsNCT07246668
What this trial is testing

A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver NeoplasmsCarcinoma+1 more
Yonsei University 52
Testing effectiveness (Phase 2)Study completedNCT00510250
What this trial is testing

A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer

Who this might be right for
Cancer of the Cervix
University Health Network, Toronto 13
Not applicableUnknownNCT05202626
What this trial is testing

Detection and Biopsy Guidance of Nasopharyngeal Carcinoma Based on Artificial Intelligence and Endoscopic Images

Who this might be right for
Nasopharyngeal CarcinomaImage-Guided Biopsy
Chinese Academy of Sciences 100
Next Page